Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
Plos One|December 12, 2025
Blood RNA biomarkers and a point-of-care elastase assay for detecting host immune activation in suspected sepsis: Trajectory mattersJohn E Lafleur, Eduard Shaykhinurov, John Perkins, et al.Nature Human Behaviour|July 4, 2024
Principled distillation of UK Biobank phenotype data reveals underlying structure in human variationCaitlin E Carey, Rebecca Shafee, Robbee Wedow, et al.Gastroenterology|August 25, 2015
Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer CellsValen Zhuoyou Yu, Victor Chun-Lam Wong, Wei Dai, et al.BMJ Open|September 29, 2022
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for type 2 diabetes remission (ORDER): protocol of a multicentre, randomised controlled, open-label, superiority trialMengyi Li, Yang Liu, Wei-Jei Lee, et al.Molecular & Cellular Proteomics : MCP|August 21, 2015
A High Through-put Platform for Recombinant Antibodies to Folded ProteinsMichael Hornsby, Marcin Paduch, Shane Miersch, et al.Nature Genetics|September 18, 2025
Pan-UK Biobank genome-wide association analyses enhance discovery and resolution of ancestry-enriched effectsKonrad J Karczewski, Rahul Gupta, Masahiro Kanai, et al.JCO Precision Oncology|March 6, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working GroupLakshmi Rajdev, Gentry G King, Christopher H Lieu, et al.Journal of Medicinal Chemistry|October 20, 2018
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant CancersJulien P N Papillon, Katsumasa Nakajima, Christopher D Adair, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic CancerJennifer J Knox, Grainne O'Kane, Daniel King, et al.Nature Genetics|October 6, 2015
Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 familiesNadia Akawi, Jeremy McRae, Morad Ansari, et al.Pageof 13